150 related articles for article (PubMed ID: 16623821)
1. IgG monitoring to identify the risk for development of infection in heart transplant recipients.
Sarmiento E; Rodriguez-Molina JJ; Fernandez-Yañez J; Palomo J; Urrea R; Muñoz P; Bouza E; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2006 Mar; 8(1):49-53. PubMed ID: 16623821
[TBL] [Abstract][Full Text] [Related]
2. Decreased levels of serum immunoglobulins as a risk factor for infection after heart transplantation.
Sarmiento E; Rodríguez-Molina J; Muñoz P; Fernández-Yánez J; Palomo J; Fogueda M; Fernández-Cruz E; Bouza E; Carbone J
Transplant Proc; 2005 Nov; 37(9):4046-9. PubMed ID: 16386623
[TBL] [Abstract][Full Text] [Related]
3. Humoral and cellular immune monitoring might be useful to identify liver transplant recipients at risk for development of infection.
Carbone J; Micheloud D; Salcedo M; Rincon D; Bañares R; Clemente G; Jensen J; Sarmiento E; Rodriguez-Molina J; Fernandez-Cruz E
Transpl Infect Dis; 2008 Dec; 10(6):396-402. PubMed ID: 18657086
[TBL] [Abstract][Full Text] [Related]
4. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
[TBL] [Abstract][Full Text] [Related]
5. The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections.
Carbone J; Sarmiento E; Palomo J; Fernandez-Yañez J; Muñoz P; Bouza E; Rodríguez-Molina J; Lanio N; Fernandez-Cruz E
Transplant Proc; 2007 Sep; 39(7):2385-8. PubMed ID: 17889198
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an immunological score to assess the risk of severe infection in heart recipients.
Sarmiento E; Navarro J; Fernandez-Yañez J; Palomo J; Muñoz P; Carbone J
Transpl Infect Dis; 2014 Oct; 16(5):802-12. PubMed ID: 25179534
[TBL] [Abstract][Full Text] [Related]
7. Limited cytomegalovirus-specific immunoglobulin M and immunoglobulin G profiles in heart transplant recipients.
Allen MD; Denny CF; Kruse AP; Revkin JH; Fishbein DP; Ashley RL
J Heart Lung Transplant; 1991; 10(5 Pt 1):664-73. PubMed ID: 1659902
[TBL] [Abstract][Full Text] [Related]
8. Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients.
Sarmiento E; del Pozo N; Gallego A; Fernández-Yañez J; Palomo J; Villa A; Ruiz M; Muñoz P; Rodríguez C; Rodríguez-Molina J; Navarro J; Kotsch K; Fernandez-Cruz E; Carbone J
Transpl Infect Dis; 2012 Oct; 14(5):526-39. PubMed ID: 23013361
[TBL] [Abstract][Full Text] [Related]
9. Post-operative nosocomial infections after lung and heart transplantation.
Mattner F; Fischer S; Weissbrodt H; Chaberny IF; Sohr D; Gottlieb J; Welte T; Henke-Gendo C; Gastmeier P; Strueber M
J Heart Lung Transplant; 2007 Mar; 26(3):241-9. PubMed ID: 17346626
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
Schubert S; Abdul-Khaliq H; Lehmkuhl HB; Yegitbasi M; Reinke P; Kebelmann-Betzig C; Hauptmann K; Gross-Wieltsch U; Hetzer R; Berger F
Pediatr Transplant; 2009 Feb; 13(1):54-62. PubMed ID: 18518912
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study.
Sarmiento E; Jaramillo M; Calahorra L; Fernandez-Yañez J; Gomez-Sanchez M; Crespo-Leiro MG; Paniagua M; Almenar L; Cebrian M; Rabago G; Levy B; Segovia J; Gomez-Bueno M; Lopez J; Mirabet S; Navarro J; Rodriguez-Molina JJ; Fernandez-Cruz E; Carbone J
J Heart Lung Transplant; 2017 May; 36(5):529-539. PubMed ID: 27866926
[TBL] [Abstract][Full Text] [Related]
12. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
Potena L; Holweg CT; Chin C; Luikart H; Weisshaar D; Narasimhan B; Fearon WF; Lewis DB; Cooke JP; Mocarski ES; Valantine HA
Transplantation; 2006 Aug; 82(3):398-405. PubMed ID: 16906040
[TBL] [Abstract][Full Text] [Related]
13. Impact of Chlamydia pneumoniae infection on survival rate after heart transplantation.
Pieniazek P; Stepień E; Sadowski J; Przewłocki T; Sokołowski A; Podolec P; Kapelak B; Przybyłowski P; Kadzielski A; Tracz W
Med Sci Monit; 2003 Feb; 9(2):CR67-72. PubMed ID: 12601289
[TBL] [Abstract][Full Text] [Related]
14. [Infectious complications of heart transplantation. A prospective study for the first 6 years of a transplantation program].
Bernabeu-Wittel M; Cañas García-Otero E; Herrero Romero M; Ordóñez Fernández A; Martínez Martínez A; Pérez Bernal J; Cisneros Herreros JM
Rev Clin Esp; 1999 Aug; 199(8):489-95. PubMed ID: 10522428
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and risk factors for late infection in solid organ transplant recipients.
Cervera C; Fernández-Ruiz M; Valledor A; Linares L; Antón A; Ángeles Marcos M; Sanclemente G; Hoyo I; Cofán F; Ricart MJ; Pérez-Villa F; Navasa M; Pumarola T; Moreno A
Transpl Infect Dis; 2011 Dec; 13(6):598-607. PubMed ID: 21535336
[TBL] [Abstract][Full Text] [Related]
16. Pre-transplant Toxoplasma gondii seropositivity among heart transplant recipients is associated with an increased risk of all-cause and cardiac mortality.
Arora S; Jenum PA; Aukrust P; Rollag H; Andreassen AK; Simonsen S; Gude E; Fiane AE; Geiran O; Gullestad L
J Am Coll Cardiol; 2007 Nov; 50(20):1967-72. PubMed ID: 17996562
[TBL] [Abstract][Full Text] [Related]
17. Case-control study of risk factors for the development of post-transplant lymphoproliferative disease in a pediatric heart transplant cohort.
Katz BZ; Pahl E; Crawford SE; Kostyk MC; Rodgers S; Seshadri R; Proytcheva M; Pophal S
Pediatr Transplant; 2007 Feb; 11(1):58-65. PubMed ID: 17239124
[TBL] [Abstract][Full Text] [Related]
18. Hypogammaglobulinemia in liver transplant recipients: incidence, timing, risk factors, and outcomes.
Doron S; Ruthazer R; Werner BG; Rabson A; Snydman DR
Transplantation; 2006 Mar; 81(5):697-703. PubMed ID: 16534471
[TBL] [Abstract][Full Text] [Related]
19. Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay.
Cadillo-Chávez R; de Echegaray S; Santiago-Delpín EA; Rodríguez-Trinidad AT; Camacho-Carrazo B; Alfaro T; Saavedra-Pozo M; Carrasquillo L; González-Caraballo ZA; Morales-Otero LA
Transplant Proc; 2006 Apr; 38(3):918-20. PubMed ID: 16647510
[TBL] [Abstract][Full Text] [Related]
20. Cryoglobulinemia in kidney transplant recipients.
Sens YA; Malafronte P; Souza JF; Bruno S; Gonzalez RB; Miorin LA; Jabur P; Forte WC
Transplant Proc; 2005 Dec; 37(10):4273-5. PubMed ID: 16387095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
